Fatty acid synthase: a new anti-tumor target

被引：6

作者：

Puig, Teresa ^{[1
,2
]}

Porta, Rut ^{[1
]}

Colomer, Ramon ^{[1
,3
]}

机构：

[1] Hosp Univ Dr Josep Trueta, Inst Invest Biomed Girona IdIBGi, Inst Catalan Oncol ICO Girona, Girona, Spain

[2] Univ Girona UdG, Fac Med, Girona, Spain

[3] Ctr Oncol MD Anderson Espana, Madrid, Spain

来源：

MEDICINA CLINICA | 2009年 / 132卷 / 09期

关键词：

Cancer; Fatty acid metabolism; Fatty acid synthase; New antitumor drugs; COA-CARBOXYLASE-ALPHA; BREAST-CANCER CELLS; PROSTATE-CANCER; GREEN TEA; THERAPEUTIC TARGET; FAS EXPRESSION; INCREASED RISK; FOOD-INTAKE; INHIBITION; ACTIVATION;

D O I：

10.1016/j.medcli.2008.07.022

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Fatty acid synthase (FASN), an enzyme capable of de novo fatty acid synthesis, is highly expressed and activated in most human carcinomas. FASN is associated with poor prognosis in prostate and breast cancer and its inhibition is selectively cytotoxic to human cancer cells. Thus, FASN and fatty acid metabolism have become an important focus for the diagnostic and treatment of cancer. In this sense, there is an increasing interest in identifying and developing new antitumor compounds that inhibit FASN. (C) 2008 Elsevier Espana, S.L. All rights reserved.

引用

页码：359 / 363

页数：5

共 50 条

[1] Fatty acid synthase as a novel target for meningioma therapy
Haase, Daniela
Schmidl, Stefan
Ewald, Christian
Kalff, Rolf
Huebner, Christian
Firsching, Raimund
Keilhoff, Gerburg
Evert, Matthias
Paulus, Werner
Gutmann, David H.
Lal, Anita
Mawrin, Christian
NEURO-ONCOLOGY, 2010, 12 (08) : 844 - 854
[2] Fatty acid synthase as a potential therapeutic target in cancer
Flavin, Richard
Peluso, Stephane
Nguyen, Paul L.
Loda, Massimo
FUTURE ONCOLOGY, 2010, 6 (04) : 551 - 562
[3] Anti-Cancer Drugs Targeting Fatty Acid Synthase (FAS)
Pandey, Puspa R.
Liu, Wen
Xing, Fei
Fukuda, Koji
Watabe, Kounosuke
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2012, 7 (02) : 185 - 197
[4] Fatty acid synthase as a potential new therapeutic target for cervical cancer
Nascimento, Jessica
Mariot, Camila
Vianna, Debora R. B.
Kliemann, Lucia M.
Chaves, Paula S.
Loda, Massimo
Buffon, Andreia
Beck, Ruy C. R.
Pilger, Diogo A.
ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS, 2022, 94 (02):
[5] Novel anti-fatty acid synthase compounds with anti-cancer activity in HER2+ breast cancer
Oliveras, G.
Blancafort, A.
Urruticoechea, A.
Campuzano, O.
Gomez-Cabello, D.
Brugada, R.
Lopez-Rodriguez, M. L.
Colomer, R.
Puig, T.
TOWARD PERSONALIZED MEDICINE FOR CANCER, 2010, 1210 : 86 - 93
[6] Fatty Acid Synthase: An Emerging Target in Cancer
Fhu, Chee Wai
Ali, Azhar
MOLECULES, 2020, 25 (17):
[7] Impact of IGF system on dietary short chain fatty acid-induced anti-inflammatory and anti-tumor effects
Mohanraj, Lathika
Oh, Youngman
BIOMEDICAL RESEARCH-INDIA, 2012, 23 : 187 - 195
[8] Pharmacological inhibitors of fatty acid synthase (FASN)-catalyzed endogenous fatty acid biogenesis: A new family of anti-cancer agents?
Lupu, Ruth
Menendez, Javier A.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2006, 7 (06) : 483 - 494
[9] Positive feedback regulation between Akt phosphorylation and fatty acid synthase expression in osteosarcoma
Wang, Heng
Luo, Qing Feng
Peng, Ai Fen
Long, Xin Hua
Wang, Tao Fang
Liu, Zhi Li
Zhang, Guo Mei
Zhou, Rong Ping
Gao, Song
Zhou, Yang
Chen, Wen Zhao
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 33 (03) : 633 - 639
[10] Fatty acid synthase: Specific target for cancer therapy
Li, XH
Hou, YT
ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2003, 35 (01) : 1 - 5

← 1 2 3 4 5 →